Genomics BioSci & Tech Co., Ltd. logo

Genomics BioSci & Tech Co., Ltd. (4195)

Market Closed
10 Jul, 05:30
TWSE TWSE
NT$
17. 85
0
0%
NT$
1.35B Market Cap
- P/E Ratio
- Div Yield
553,001 Volume
- Eps
NT$ 17.85
Previous Close
Add Transaction
Day Range
17.85 17.85
Year Range
15.1 36.85
Want to track 4195 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4195 closed Friday higher at NT$17.85, an increase of 0% from Thursday's close, completing a monthly increase of 10.5263% or NT$1.7. Over the past 12 months, 4195 stock lost -30.5447%.
4195 is not paying dividends to its shareholders.
Genomics BioSci & Tech Co., Ltd. has completed 2 stock splits, with the recent split occurring on Aug 08, 2023.
The company's stock is traded on one exchange.

4195 Chart

People also search for

Chunghwa Chemical Synthesis & Biotech Co., Ltd.
NT$ 36.1
-1.3661%
Chang Type Industrial Co., Ltd.
NT$ 21.5
-2.0501%
Sheh Fung Screws Co., Ltd.
NT$ 37.5
+6.383%
Taiwan Name Plate Co., Ltd.
NT$ 32.45
0%
Sinher Technology Inc.
NT$ 18.95
-1.8135%

Genomics BioSci & Tech Co., Ltd. (4195) FAQ

What is the stock price today?

The current price is NT$17.85.

On which exchange is it traded?

Genomics BioSci & Tech Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4195.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.35B.

Has Genomics BioSci & Tech Co., Ltd. ever had a stock split?

Genomics BioSci & Tech Co., Ltd. had 2 splits and the recent split was on Aug 08, 2023.

Genomics BioSci & Tech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
TWSE Exchange
TW0004195003 ISIN
Taiwan Country
- Employees
- Last Dividend
8 Aug 2023 Last Split
- IPO Date

Overview

Genomics BioSci & Tech. Co.,Ltd., founded in 2001 and headquartered in New Taipei City, Taiwan, is a pioneering company in the field of genome sequencing. The company is dedicated to providing a wide array of services related to DNA and gene sequencing, catering to the needs of diverse scientific research and medical diagnostics. With an emphasis on quality and innovation, Genomics BioSci & Tech. Co.,Ltd. has established itself as a key player in the fast-evolving genomics industry.

Products and Services

  • Regular DNA and Complex Sequence Sequencing: Offers comprehensive sequencing services for various DNA types, accommodating both simple and complex genetic sequences.
  • TAF Certificated Sequencing Services: Ensures high-quality sequencing results that meet the rigorous standards set by the Taiwan Accreditation Foundation (TAF).
  • Free Sequencing Primer and Primer Walking Services: Provides complimentary services for sequencing primer selection and sequencing of long DNA strands through primer walking techniques.
  • Peptide, Gene, and Oligo Synthesis Services: Offers custom synthesis services for peptides, genes, and oligonucleotides to support research and therapeutic development.
  • Sample Preparation and Gene Expression Analysis: Prepares samples for sequencing and analyzes gene expression levels to gain insights into gene function and regulation.
  • Genotyping Analysis and DNA Methylation Analysis: Provides genotyping services to identify genetic variants, along with analysis of DNA methylation patterns to understand epigenetic modifications.
  • Microbial Identification Services: Utilizes sequencing technologies for the identification and classification of microbial species in various samples.
  • Genome-level, Targeted, Gene Regulation, and Metagenomic Sequencing Services: Offers a suite of sequencing services to explore the genome broadly or target specific areas, study gene regulation mechanisms, and analyze the genetic material of microbial communities.
  • Third Generation Sequencing Services: Provides cutting-edge sequencing technologies for real-time, long-read sequencing applications, enhancing the understanding of complex genomes.
  • Sequencing Platforms and Workflow: Utilizes multiple sequencing platforms and a streamlined workflow to deliver accurate and efficient sequencing results.
  • Non-invasive Prenatal Test, Spinal Muscular Atrophy Carrier Screening, and Fragile X Syndrome Premutation Screening Services: Offers advanced genetic screening services for prenatal testing and carrier status determination, fostering early detection and intervention for genetic disorders.

Contact Information

Address: No.100, Sintai 5th Road
Phone: 886 2 2696 1658